109 related articles for article (PubMed ID: 1645502)
1. Case report: cisplatin-induced hemolytic uremic syndrome.
Khansur T; Kennedy A
Am J Med Sci; 1991 Jun; 301(6):390-2. PubMed ID: 1645502
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide].
Tsutsumi T; Kawakami A; Ozawa Y; Kawaguchi H; Fujii H; Sawano T; Asamoto H
Gan To Kagaku Ryoho; 1991 May; 18(6):1003-6. PubMed ID: 1851407
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: a report of a case and a review of the literature.
Gardner G; Mesler D; Gitelman HJ
Ren Fail; 1989; 11(2-3):133-7. PubMed ID: 2482985
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column.
Watson PR; Guthrie TH; Caruana RJ
Cancer; 1989 Oct; 64(7):1400-3. PubMed ID: 2528403
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy-associated hemolytic uremic syndrome--a case report].
Kikuchi H; Kanamaru R
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1927-9. PubMed ID: 1519930
[TBL] [Abstract][Full Text] [Related]
7. [The effect of combination chemotherapy with cisplatin, vincristine, doxorubicin and etoposide (Tokushima-CODE: T-CODE) against lung cancer].
Yanagawa H; Bando H; Takishita Y; Shinohara T; Tanaka H
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1403-5. PubMed ID: 1323959
[No Abstract] [Full Text] [Related]
8. [Etoposide and cisplatin combination chemotherapy in a patient with small cell lung carcinoma under artificial hemodialysis].
Ono S; Miyazaki T; Nishikawa K; Watanabe K; Hisanaga S
Gan To Kagaku Ryoho; 1992 Jan; 19(1):115-8. PubMed ID: 1309629
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study.
Davis S; Tonato M; Crinò L; Colozza MA; Lubansky K; Grignani F
Cancer; 1986 Sep; 58(5):1018-9. PubMed ID: 3015372
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx.
Thurnher D; Kletzmayr J; Formanek M; Quint C; Czerny C; Burian M; Kornek G
Oncology; 2001; 61(2):143-6. PubMed ID: 11528253
[TBL] [Abstract][Full Text] [Related]
11. Haemolytic uraemic syndrome associated with bleomycin, epirubicin and cisplatin chemotherapy--a case report and review of the literature.
van der Heijden M; Ackland SP; Deveridge S
Acta Oncol; 1998; 37(1):107-9. PubMed ID: 9572663
[No Abstract] [Full Text] [Related]
12. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
Cantrell JE; Phillips TM; Schein PS
J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
[TBL] [Abstract][Full Text] [Related]
13. [Mitomycin C, adriamycin and vinblastine after induction with cisplatin and VP-16 in the treatment of non-small cell lung carcinoma].
De Marinis A; Mugnaini L; Antilli A; Mollica C; Mecarocci D; Conte S; Salvati F
G Ital Chemioter; 1985; 32(1):73-5. PubMed ID: 3007255
[No Abstract] [Full Text] [Related]
14. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
Evans WK; Stewart D; Logan D; Maroun J; Goss G; Shepherd FA; Latreille J; Warner E; Dahrouge S
Semin Oncol; 1992 Dec; 19(6 Suppl 12):51-6. PubMed ID: 1336622
[TBL] [Abstract][Full Text] [Related]
16. [Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin].
Takahashi T; Mori K; Suga Y; Tominaga K
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1873-5. PubMed ID: 8397491
[No Abstract] [Full Text] [Related]
17. Subacute encephalopathic toxicity of cisplatin.
Verschraegen C; Conrad CA; Hong WK
Lung Cancer; 1995 Dec; 13(3):305-9. PubMed ID: 8719070
[TBL] [Abstract][Full Text] [Related]
18. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
Saito R; Tsuchiya S; Minato K; Ishizuka T
Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):744-51. PubMed ID: 2841389
[No Abstract] [Full Text] [Related]
19. Can Carboplatin replace Cisplatin in small cell lung cancer?
Noronha V
Indian J Cancer; 2011; 48(4):452-3. PubMed ID: 22293259
[No Abstract] [Full Text] [Related]
20. [A cisplatin and etoposide combination in small cell anaplastic carcinoma of the lung].
Nuzzo A; Morera E; Ursini LA; Peretti G; Balice A; Basilico L
Clin Ter; 1987 Feb; 120(4):299-302. PubMed ID: 3034479
[No Abstract] [Full Text] [Related]
[Next] [New Search]
